Drug Fight Dismissed

Published: May 04, 2004

Lake Forest-based biotech firm NeoPharm Inc. and pharmaceutical giant Pfizer Inc. will be left to iron out an agreement to develop cancer drugs after a ruling from an independent panel of arbitrators dismissed claims each company had made against the other. The two companies have been at odds over a 1999 licensing agreement and Pfizer's role in developing two Neopharm cancer compounds. The dispute began two years ago between NeoPharm and Pharmacia Corp., which was purchased last year by Pfizer.

Back to news